Gastrointestinal Absorption of Pravastatin in Healthy Subjects
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Disposition of pravastatin sodium, a tissue‐selective HMG‐CoA reductase inhibitor, in healthy subjects.
1990 • 174 citations
Lipid Emulsions as Drug Delivery Systems
1987 • 142 citations
Biotransformation of pravastatin sodium in humans.
1991 • 108 citations
Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia
1990 • 82 citations
Single‐Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal Impairment
1992 • 52 citations
Biological approaches to the controlled delivery of drugs.
1987 • 51 citations
Delivery of Lipophilic Drugs Using Lipoproteinsa
1987 • 50 citations
Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometry
1989 • 47 citations
Pharmacokinetic interaction between propranolol and the HMG‐CoA reductase inhibitors pravastatin and lovastatin.
1991 • 43 citations
Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase.
1991 • 40 citations
Clinical Implications of New Drugs for Lowering Plasma Cholesterol Concentrations
1991 • 34 citations
Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase
1991 • 23 citations